SIDD-2025: Pioneering Sustainable Drug Innovation at Indrashil University, Kadi Gujarat
Ahmedabad, 19th March 2025: Gujarat is set to witness a groundbreaking event from 24–26 March 2025, as Indrashil University, Kadi—a GSIRF 4-Star Rated Institution and a proud Educational initiative of the Cadila Pharmaceuticals—presents SIDD (Sustainable Innovations in Drug Development) -2025.
With top minds from academia, industry, and research, this premier conference will drive sustainable innovation in drug development. As a hub for graduate, postgraduate, and research programs in Science, Engineering, and Pharmacy, SIDD-2025 will focus on advancing translational research to revolutionize the pharmaceutical landscape.
The conference will feature renowned scientific leaders delivering keynote and plenary lectures, ensuring a nationwide scientific impact and reinforcing India's leadership in the pharmaceutical sector. A key highlight of the event will be the Students' Special Interactive Session, where distinguished academicians and industry experts will mentor young minds and emphasize the critical role of translational research in bridging academia and industry gaps.
The participation of eminent scientists and industry professionals presents a rare opportunity for attendees to engage in meaningful knowledge exchange and extensive networking, with remote participants also gaining significant insights.
Adding to its prestige, SIDD-2025 will offer special awards on behalf of the Royal Society of Chemistry (RSC) and American Chemical Society (ACS) in the name of their flagship journals, recognizing groundbreaking contributions in the thematic areas like Natural Product Synthesis, Asymmetric Catalysis, Medicinal Chemistry, and Drug Development. This makes the conference a career-defining platform for young scientists and emerging researchers.
Moreover, direct collaborations with industry leaders and dedicated networking opportunities will enhance participants' professional growth, fostering stronger industry-academia ties.
Aligning with national initiatives like "Make in India" and "Viksit Bharat 2047", SIDD-2025 aims to inspire the next generation of scientists and entrepreneurs by promoting sustainable drug development. The conference is set to significantly bolster the visibility and brand positioning of Cadila Pharmaceuticals and Indrashil University on a PAN-India scale.
About Cadila Pharmaceuticals Limited
Cadila Pharmaceuticals Ltd. is one of India's leading integrated privately held pharmaceutical firms, located in Ahmedabad, Gujarat.
The firm develops and produces pharmaceutical products in India and sells and distributes them in over 100 countries. The organization places a high emphasis and priority on research, whether it is in biotechnology, APIs, formulations, plant tissue culture, or phytochemistry to innovate in various therapeutic areas including gastrointestinal, cardiology, pulmonary, oncology, gynaecology, cardiovascular, diabetology, and osteology.
Its undaunted commitment to create affordable miracles in therapeutic areas with significant unmet medical needs to serve society and the community at large has led to several world-first breakthroughs.
Issued By:
Jatin Aggarwal
President – Cadila Pharmaceuticals Limited
Email: Jatin.aggarwal@cadilapharma.com